Literature DB >> 8311072

Role of iron and oxygen radicals in the progression of chronic renal failure.

A C Alfrey1.   

Abstract

As nephron population is lost from injury or disease the remaining nephrons undergo functional and anatomic hypertrophy. The compensatory or secondary events responsible for these changes may exert a detrimental effect on the remaining nephrons that ultimately leads to their destruction. Most studies have examined how these alterations cause glomerular injury. Although glomerular injury and functional alterations are the initial result of these events, tubulointerstitial disease may be the major determinate of subsequent nephron loss and progressive renal failure. Proteinuria has been used largely as an indicator of the severity of the glomerular involvement. However, an alternative hypothesis is that the proteinuria, resulting from the glomerular injury, actually perpetuates renal injury as a result of its damaging effect on renal tubules and the surrounding interstitium. Because of being the major protein fraction it has been assumed that albumin is largely, if not solely, responsible for the induction of tubulointerstitial injury. However, with glomerular disease all protein classes can be excreted. One protein of interest is transferrin. In association with the glomerular transferrin leak, iron also would be presented to the tubule fluid. Iron is a transition element capable of catalyzing the Haber Weiss reaction with formation of hydroxyl radicals. Normally, iron is maintained in a nonreactive state in virtually all biologic tissues and fluid. However, at the reduced pH of tubule fluid iron can dissociate from transferrin and assume a reactive state capable of catalyzing hydroxyl radical formation. The kidney in patients with the nephrotic syndrome appears to be unduly susceptible to free radical injury, as documented by its increase iron content in association with depletion of copper and selenium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311072     DOI: 10.1016/s0272-6386(12)80969-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

Authors:  Masaru Motojima; Atsuko Hosokawa; Hideyuki Yamato; Takamura Muraki; Toshimasa Yoshioka
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome.

Authors:  Huseyin Begenik; Yasemin Usul Soyoral; Reha Erkoc; Habib Emre; Abdullah Taskın; Mehmet Tasdemir; Mehmet Aslan
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

3.  Cardiac and Renal Delayed Effects of Acute Radiation Exposure: Organ Differences in Vasculopathy, Inflammation, Senescence and Oxidative Balance.

Authors:  Joseph L Unthank; Miguel Ortiz; Hina Trivedi; Louis M Pelus; Carol H Sampson; Rajendran Sellamuthu; Alexa Fisher; Hui Lin Chua; Artur Plett; Christie M Orschell; Eric P Cohen; Steven J Miller
Journal:  Radiat Res       Date:  2019-03-22       Impact factor: 2.841

4.  Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Mehmet Davutoğlu; Yüksel Koçyiğit; Murat Tutanç
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

5.  Apoptosis and antioxidant defense in the nephrotic syndrome.

Authors:  Jacek Zachwieja; Waldemar Bobkowski; Marcin Zaniew; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2003-09-05       Impact factor: 3.714

6.  Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.

Authors:  Ludovica Aliberti; Irene Gagliardi; Maria Rita Gamberini; Andrea Ziggiotto; Martina Verrienti; Aldo Carnevale; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
Journal:  Br J Haematol       Date:  2022-06-29       Impact factor: 8.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.